0.88
+0.0384(+4.59%)
Currency In USD
| Previous Close | 0.84 |
| Open | 0.83 |
| Day High | 0.88 |
| Day Low | 0.82 |
| 52-Week High | 5.5 |
| 52-Week Low | 0.31 |
| Volume | 655,679 |
| Average Volume | 7.96M |
| Market Cap | 24.43M |
| PE | -0.47 |
| EPS | -1.85 |
| Moving Average 50 Days | 0.74 |
| Moving Average 200 Days | 1.42 |
| Change | 0.04 |
If you invested $1000 in SeaStar Medical Holding Corporation (ICU) since IPO date, it would be worth $1.4M as of September 10, 2025 at a share price of $0.875. Whereas If you bought $1000 worth of SeaStar Medical Holding Corporation (ICU) shares 3 years ago, it would be worth $3.42 as of September 10, 2025 at a share price of $0.875.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Sep 04, 2025 10:13 PM GMT
DENVER, Sept. 04, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, anno
SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival
GlobeNewswire Inc.
Sep 02, 2025 12:22 PM GMT
Study shows approximately 18% savings per hospitalizationDENVER, Sept. 02, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patie
SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025
GlobeNewswire Inc.
Aug 07, 2025 2:00 PM GMT
DENVER, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, annou